| Literature DB >> 34435043 |
Te-Ju Wu1, Cheng-Chun Wu2, Chi-Yu Tsai1, Yi-Hao Lee1, Yu-Jen Chang1, Shiu-Shiung Lin1, Jui-Pin Lai2.
Abstract
BACKGROUND: The orthognathic strategies to treat patients with a concave profile but different tissue conditions remain controversial. The aim of this case-control study was to investigate the outcome predictability of orthognathic surgery in cleft lip and palate (CLP) patients and matched controls.Entities:
Mesh:
Year: 2021 PMID: 34435043 PMCID: PMC8380494 DOI: 10.1155/2021/4572397
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1(a) Reverse engineering was applied to fabricate the surgical guide. A stereolithographic model demonstrating the planned maxillary reposition was produced. The fixation miniplates serving as the guiding plate (the 2nd guiding plate) were prebent according to the plate holes marked on the model. (b) Anterior nasal spine (ANS) and infrazygomatic crest (IZC) were used as reference structures for designing the guiding plate on the presurgical virtual maxilla. (c, d) The mandibular guiding plates were also fabricated according to the final position of MMC to provide predicted amounts of the movements of the mandibular segments intraoperatively.
Figure 2The virtual triangles representing orientation of the maxilla in different stages (yellow: simulation, blue: 6-month outcome) were used for the outcome assessments. All the three-dimensional images were registered on the same coordination system.
The angular and translational outcome differences from simulation models of all samples (one-sample t-test).
| Groups | Non-CLP (45) | BCLP (17) | UCLP (33) | |||
|---|---|---|---|---|---|---|
| Outcome discrepancy | Mean | Mean | Mean | |||
| Translational (mm) | ||||||
| A-X | 0.66 ± 0.53 | 0.000∗ | 0.69 ± 0.53 | 0.000∗ | 0.61 ± 0.48 | 0.000∗ |
| A-Y | 0.69 ± 0.73 | 0.000∗ | 1.15 ± 0.83 | 0.000∗ | 0.96 ± 0.89 | 0.000∗ |
| A-Z | 0.73 ± 0.66 | 0.000∗ | 1.38 ± 1.39 | 0.000∗ | 0.83 ± 0.68 | 0.000∗ |
| MxR-X | 0.61 ± 0.44 | 0.000∗ | 0.80 ± 0.66 | 0.000∗ | 0.71 ± 0.52 | 0.000∗ |
| MxR-Y | 1.08 ± 0.95 | 0.000∗ | 1.72 ± 1.14 | 0.000∗ | 1.06 ± 0.93 | 0.000∗ |
| MxR-Z | 0.99 ± 0.71 | 0.000∗ | 0.93 ± 0.70 | 0.000∗ | 1.08 ± 0.91 | 0.000∗ |
| MxL-X | 0.63 ± 0.48 | 0.000∗ | 0.84 ± 0.76 | 0.000∗ | 0.69 ± 0.49 | 0.000∗ |
| MxL-Y | 0.75 ± 0.75 | 0.000∗ | 1.31 ± 1.11 | 0.000∗ | 1.20 ± 1.14 | 0.000∗ |
| MxL-Z | 1.12 ± 0.74 | 0.000∗ | 1.62 ± 1.02 | 0.000∗ | 1.23 ± 0.80 | 0.000∗ |
| Angular (°) | ||||||
| Roll | 0.94 ± 0.81 | 0.000∗ | 1.34 ± 0.88 | 0.000∗ | 1.16 ± 0.77 | 0.000∗ |
| Pitch | 1.97 ± 1.62 | 0.000∗ | 2.64 ± 2.86 | 0.000∗ | 2.34 ± 1.71 | 0.000∗ |
| Yaw | 1.07 ± 0.86 | 0.000∗ | 1.72 ± 1.13 | 0.000∗ | 1.13 ± 0.87 | 0.000∗ |
∗The mean difference is significant at the 0.05 level.
Comparison of the PSMs of all samples (ANOVA).
| Groups | Scheffe | ||||||
|---|---|---|---|---|---|---|---|
| Outcome discrepancy | Non-CLP (45) | BCLP (17) | UCLP (33) | N@-B# | N-U% | B-U | |
| Translational (mm) | |||||||
| A-X | 1.05 ± 0.91 | 1.56 ± 1.38 | 1.74 ± 1.37 | 0.032∗ | -0.51 | -0.69∗ | -0.19 |
| A-Y | 3.22 ± 1.39 | 4.91 ± 1.91 | 4.26 ± 2.02 | 0.001∗ | -1.69∗ | -1.05∗ | 0.64 |
| A-Z | 1.43 ± 1.01 | 1.54 ± 1.95 | 1.13 ± 1.02 | 0.436 | -0.11 | 0.30 | 0.41 |
| MxR-X | 0.73 ± 0.84 | 1.29 ± 1.55 | 1.28 ± 0.92 | 0.037∗ | -0.55 | 0.55 | 0.006 |
| MxR-Y | 3.55 ± 1.69 | 4.84 ± 2.44 | 5.26 ± 3.25 | 0.009∗ | -1.29 | -1.71∗ | -0.42 |
| MxR-Z | 2.82 ± 1.75 | 1.99 ± 2.66 | 2.14 ± 1.42 | 0.156 | 0.83 | 0.68 | -0.15 |
| MxL-X | 0.72 ± 0.77 | 1.21 ± 1.61 | 1.20 ± 0.81 | 0.061 | -0.49 | -0.48 | 0.00 |
| MxL-Y | 2.82 ± 1.76 | 4.84 ± 2.09 | 3.94 ± 2.29 | 0.001∗ | -2.02∗ | -1.12 | 0.90 |
| MxL-Z | 2.88 ± 1.72 | 1.27 ± 0.69 | 2.05 ± 2.17 | 0.005∗ | 1.61∗ | 0.83 | -0.77 |
| Angular (°) | |||||||
| Roll | 1.30 ± 1.08 | 2.67 ± 4.93 | 2.10 ± 1.75 | 0.106 | -1.37 | -0.80 | 0.57 |
| Pitch | 4.25 ± 2.65 | 4.33 ± 3.69 | 2.29 ± 2.40 | 0.006∗ | -0.09 | 1.96∗ | 2.04 |
| Yaw | 1.63 ± 1.74 | 2.09 ± 1.53 | 3.47 ± 2.98 | 0.002∗ | -0.46 | -1.84∗ | -1.38 |
∗The mean difference is significant at the 0.05 level; @Non-CLP patients; #patients with bilateral cleft lip and palate; %patients with unilateral cleft lip and palate.
ANCOVA on outcome discrepancies and characteristics of the samples.
| Regression coefficients ( | ||||
|---|---|---|---|---|
| Outcome discrepancy | PSM | N@-B# | N-U% | B-U |
| Translational (mm) | ||||
| A-X | 0.018 | 0.021 | -0.066 | 0.087 |
| A-Y | 0.089 | 0.312 | 0.184 | 0.128 |
| A-Z | 0.017 | 0.642∗ | 0.097 | 0.545∗ |
| MxR-X | 0.079 | 0.146 | 0.060 | 0.086 |
| MxR-Y | 0.023 | 0.609∗ | -0.062 | 0.671∗ |
| MxR-Z | 0.007 | -0.053 | -0.088 | -0.142 |
| MxL-X | 0.170∗ | 0.128 | -0.027 | 0.155 |
| MxL-Y | 0.144∗ | 0.271 | 0.290 | -0.019 |
| MxL-Z | 0.082 | 0.627∗ | 0.181 | 0.445 |
| Angular (°) | ||||
| Roll | 0.107∗ | 0.259 | 0.138 | 0.121 |
| Pitch | 0.176∗ | 0.646 | 0.119 | -0.062 |
| Yaw | 0.136∗ | 0.592∗ | -0.193 | 0.785∗ |
∗The mean difference is significant at the 0.05 level; @non-CLP patients; #patients with bilateral cleft lip and palate; %patients with unilateral cleft lip and palate.
ROC curves were plotted to identify the cutoff value leading to ODs of clinical significance.
| AUROC | Best cutoff point | Sensitivity | Specificity | Accuracy | |
|---|---|---|---|---|---|
| Abi_AZ | |||||
| Control/unilateral | 0.684 | 1.37 | 100 | 47.9 | 52.6 |
| Bilateral | 0.810 | 1.33 | 100 | 71.4 | 76.4 |
| Abi_LZ | |||||
| Control/unilateral | 0.680 | 2.78 | 81.8 | 59.7 | 62.8 |
| Bilateral | 0.558 | 0.60 | 100 | 33.3 | 54.9 |
| RY | |||||
| Control/unilateral | 0.542 | 1.05 | 30.8% | 95.4% | 84.6% |
| Bilateral | 0.667 | 7.31 | 60.0% | 100% | 88.2% |
| Abi_yaw | |||||
| Control/unilateral | 0.678 | 2.0 | 76.9 | 60.0 | 62.8 |
| Bilateral | 0.857 | 1.65 | 100 | 70.0 | 82.4 |
The cephalometric assessments of mandibular position.
| Groups | LSD | |||||
|---|---|---|---|---|---|---|
| Outcome discrepancy | Non-CLP (45) | BCLP (17) | UCLP (33) | N@-B# | N-U% | B-U |
| Pog-Nv (sagittal OD) | 0.54 ± 2.65 | 4.30 ± 4.47 | 0.98 ± 3.83 | -3.76∗ | -0.44 | 3.32∗ |
| Me on Nv (vertical OD) | −0.36 ± 1.74 | −3.60 ± 2.53 | −0.96 ± 2.20 | -3.23∗ | 0.59 | 2.64∗ |
∗The mean difference is significant at the 0.05 level; @non-CLP patients; #patients with bilateral cleft lip and palate; %patients with unilateral cleft lip and palate.